Loading patent…
AssigneeALK-Abello A/S
InventorsHeather M. Webster, Jason Daniel Frey, Trena L. Repp, Craig T. Grass, David Rowles, Gary Smith, Domingo Barber Hernandez, Fernando Juan Vidales, Carmen Arteaga Vazquez, Juan Carlos Moreno Segura, Maria Jose Chamorro Salillas
Estimating the term…
The invention relates to a pharmaceutical product comprising an allergen extract or an allergoid thereof for the treatment and/or prevention of allergy and allergic asthma caused by house dust mites, which extract comprises at least one extract of mite bodies selected from the following groups a)-b): a) An extract of Der p mite bodies, and b) An extract of Der f mite bodies, and at least one extract of mite cultures selected from the following groups c)-g): c) An extract of Der p faecal particles, d) An extract of Der f faecal particles, e) An extract of Der f whole mite culture, f) An extract of an Der p whole mite culture, and g) a combination of extracts c) to f).
A method of manufacturing multiple batches of a pharmaceutical composition, wherein each batch of said pharmaceutical composition comprises at least two active ingredients selected from the group consisting of Der p 1, Der f 1, Der p 2 and Der f 2, and
A method of treating a patient allergic to dust mites with at least one dose of a pharmaceutical composition from a first batch and at least one dose of a pharmaceutical composition from a subsequent batch, wherein each batch of said pharmaceutical composition comprises at least two active ingredients selected from the group consisting of Der p 1, Der f 1, Der p 2 and Der f 2, and wherein the ratio of active ingredients selected from the group consisting of Der p 1, Der f 1, Der p 2 and Der f 2, respectively in said pharmaceutical composition has a batch-to-batch consistency coefficient of variation of less than 25%;
A method of treating a patient having allergic rhinitis and/or allergic asthma with at least one dose of a pharmaceutical composition from a first batch and at least one dose of a pharmaceutical composition from a subsequent batch, wherein each batch of said pharmaceutical composition comprises at least two active ingredients selected from the group consisting of Der p 1, Der f 1, Der p 2 and Der f 2, and wherein the ratio of active ingredients selected from the group consisting of Der p 1, Der f 1, Der p 2 and Der f 2, respectively in said pharmaceutical composition has a batch-to batch consistency coefficient of variation of less than 25%;
Dependencies are inferred from the claim text.